Infants in the hydrocortisone group will be treated with hydrocortisone 5 mg/kg/day Q.I.D for 7 days, followed by 3.75 mg/kg/day T.I.D. for 5 days, subsequently lowering the frequency by one dose every 5 day.
The cell growth exhibited a lag phase or slow growth period in the first 10 days; subsequently, the cells entered their exponential growth phase with the maximum DW of 8.2 g/L reached on day 20.
Then, the similarity increases with increasing window duration, reaching a maximum at ∼30 days; subsequently, the similarity begins slowly decreasing as the aggregation process captures more and more of the very weak or random links.
Study medication was infused intravenously over 30 min on days 1, 15 and 29, and every 28 days subsequently.
The body temperature of calves was assessed daily for the first 20 days, subsequently weekly until the end of experiments.
Afterwards, specimens were fixed in a mixture of ethanol, acetic acid, and formaldehyde for 1 2 days; subsequently, they were transferred to 70% ethanol for storage.
For the in vitro plate assays, plants were grown on plates in 8 h day/16 h night during 14 days, subsequently sealed with parafilm M and transferred to 12 h/12 h regime for 8 days (survival estimation).
Any factor with significant (P < .1) heterogeneity between effects in the first 0 12 days subsequently was allowed to be included in the model with this time interaction, as were any significant interactions with randomized groups (P < .1) on bivariate analyses.
A total of 277 patients with advanced ovarian cancer were randomised to either 3 or 12 months follow-on treatment with paclitaxel (initially 175 mg m−2 every 28 days, subsequently reduced to 135 mg m−2 because of concerns regarding a higher drop-out rate in the 12-month arm).
Therefore another group of 8-week-old Dll4 lox/lox Cre+ (n = 10) were treated with tamoxifen (50 mg/kg daily) for 5 days, subsequently divided in two equal subgroups that were injected with vehicle (PBS) or sEphB4-Alb (10 mg/kg) for ten weeks and then sacrificed.
